TAIPEI, December 31, 2025 /PRNewswire/ — ARTERY Technology (Caiman) Corporation (Stock Code: 6907; hereinafter referred to as “ARTERY-KY”), a leading 32-bit microcontroller (MCU) designer, is expected to be listed on the Taipei Stock Exchange (TPEx) under the Semiconductor Industry category in January 2026. The company held its first pre-IPO investor conference on December 30 (Tuesday) at the Grand Hyatt Taipei, where it presented to investors its competitive strengths and future business prospects.
As a subsidiary of Faraday Technology, ARTERY-KY focuses on the development of high-end 32-bit MCUs. Leveraging ARM® Cortex®-M4 cores with a peak peak clock speed of up to 288 MHz, the company delivers exceptional performance. In addition to successfully entering the supply chains of major global brands, ARTERY-KY has established itself as a key contributor in the Chinese market through localized technical advantages, serving as an important partner in regional supply chain transformation.
ARTERY-KY has comprehensive technical capabilities from basic architecture design to application integration. Its end-market applications cover a wide range of areas, including industrial and motor control, consumer electronics, commercial applications and vertical industries such as medical, IoT, communications and automotive electronics. With its strengths in high performance, low power consumption, superior integration and high cost efficiency, the company continues to expand in emerging applications such as drones, robotics and advanced AI, demonstrating strong market competitiveness and growth momentum.
In terms of financial performance, ARTERY-KY recorded revenue of NT$1.635 billion in 2024, a year-on-year increase of more than 60%, with earnings per share (EPS) of NT$1.67. Revenue for the first three quarters of 2025 reached NT$1.234 billion, maintaining a high level and setting a new all-time high for the same period, indicating that the company has exited the inventory adjustment cycle. Thanks to the continued optimization of its product mix, the gross margin rebounded significantly to 33.84%. Net profit after tax for the first three quarters was NT$70.52 million, with core EPS of NT$1.38, an increase of 56% year-on-year and reflecting strong profitability. As several new application projects enter mass production and orders from major customers continue to grow steadily, the market expects further optimization of the product portfolio in 2026, leading to simultaneous growth in revenue and profit.
Looking ahead, ARTERY-KY has defined three major growth strategies. First, it will establish a complete MCU foundation spanning from M0 to M85 to build a highly compatible ecosystem. Second, it will expand its custom ASIC-based MCU services to help customers quickly develop application-specific chips. Finally, the company will aggressively pursue cutting-edge AI opportunities by collaborating with UMC and Faraday Technology, using the most advanced 28-nanometer integrated Flash process to develop an intelligent inference platform. With a strategy focused on breadth, depth and forward-looking innovation, ARTERY-KY aims to fully activate its semiconductor growth engine.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/emerging-mcu-force-artery-ky-to-be-listed-on-tpex-in-january-2026-driving-high-performance-growth-through-mcu-customization-and-edge-ai-302651593.html
SOURCE ARTERY Technology Corporation
